Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Viatris Inc VTRS

Healthcare
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment consists of its operations in Japan, Australia and New Zealand... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:VTRS)

Viatris to Report First Quarter 2024 Financial Results on May 9, 2024

PR Newswire 2 days ago

Viatris Appoints Corinne Le Goff as Chief Commercial Officer

PR Newswire 4 days ago

Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada

Canada NewsWire 4 days ago

Ocuphire Announces the U.S. Commercial Launch of RYZUMVl(TM) (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris

GlobeNewswire April 1, 2024

Viatris Announces the Launch of RYZUMVl(TM) (Phentolamine Ophthalmic Solution) 0.75% in the United States

PR Newswire April 1, 2024

Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline

PR Newswire March 27, 2024

Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris

Business Wire March 11, 2024

Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance

PR Newswire February 28, 2024

Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration

PR Newswire February 28, 2024
View More News ››

Opinion & Analysis (NDAQ:VTRS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:VTRS)

Lorne Steinberg still lilkes - BNN

TOP PICK Viatris(VTRS-Q) 13/03/2023     It is the cheapest stock in their portfolio...
Possibleidiot01 - March 14, 2023

Though a small drug-maker...

 with a market capitalization of just under $14 billion, this pharmaceutical company is worth a look thanks to its consistent and...
jonahg - August 3, 2022

RE:Paul MacDonALD- BNN - Don't BUY

Lorne and Paul need to go out for a coffee and discuss further.  I have no issue holding and not worrying about this one for many...
Cdnmate23 - February 3, 2022

Paul MacDonALD- BNN - Don't BUY

DON'T BUY Viatris(VTRS-Q) 02/02/2022 at 07:00pm   Includes boring drugs, which provide...
Possibleidiot01 - February 3, 2022

RE:RE:Lorne Steinberg on BNN - BUY

Still banging the drum for the stock. PAST TOP PICK Viatris(VTRS-Q) ...
Possibleidiot01 - December 22, 2021

RE:Lorne Steinberg on BNN - BUY

STRONG BUY Viatris(VTRS-Q) PE is around 5. Cheapest stock in his portfolio. First quarter, they...
Possibleidiot01 - November 11, 2021
View more Bullboard ››

International Lithium Corp.

International Lithium Corp.

International Lithium Corp has lithium exploration properties located in Canada and Ireland. Its primary strategic focus is ...
View More »